c*r
2 楼
"Efficacy is another issue altogether, of course. The Phase I study was
designed to determine safety and feasibility, with full measures of
antitumor activity to come, Novartis said. But, reflecting the hype
surrounding CAR-T, the lack of knockout efficacy results led some investors
to cool their ambitions for the technology's potential in solid tumors
across the board, sending the shares of Novartis rivals Juno Therapeutics ($
JUNO) and Kite Pharma ($KITE) down on Monday morning."
http://www.fiercebiotech.com/story/novartis-new-car-t-hopeful-l
CART may not work so well in solid tumors.
designed to determine safety and feasibility, with full measures of
antitumor activity to come, Novartis said. But, reflecting the hype
surrounding CAR-T, the lack of knockout efficacy results led some investors
to cool their ambitions for the technology's potential in solid tumors
across the board, sending the shares of Novartis rivals Juno Therapeutics ($
JUNO) and Kite Pharma ($KITE) down on Monday morning."
http://www.fiercebiotech.com/story/novartis-new-car-t-hopeful-l
CART may not work so well in solid tumors.
l*o
3 楼
CAR-T全线回调
c*r
4 楼
CAR-T is too expensive, unsafe and limited efficacy especially in solid
tumors. Now it is time to get out!
tumors. Now it is time to get out!
C*1
5 楼
KITE和JUNO的技术哪个好？这JUNO怎么比KITE盘子大了一倍多？好像JUNO发行还在KITE
的后面。
的后面。
C*1
6 楼
KITE还有2个进入了2期，JUNO都在1期或者PRECLINICAL。
s*a
7 楼
周末的AACR会议看样子是导火索，不过Kite 和Juno两家公司都没参加，而且诺华和
upenn找5个重症病人没起作用也不能证明这个就对于其他solid tumor病人无效吧？the
street周末的文章是说他们的报告证明这个技术是安全的，我咋觉得不算是negative
news呢？
【在 C********1 的大作中提到】
: KITE还有2个进入了2期，JUNO都在1期或者PRECLINICAL。
upenn找5个重症病人没起作用也不能证明这个就对于其他solid tumor病人无效吧？the
street周末的文章是说他们的报告证明这个技术是安全的，我咋觉得不算是negative
news呢？
【在 C********1 的大作中提到】
: KITE还有2个进入了2期，JUNO都在1期或者PRECLINICAL。
s*0
8 楼
安全的但是没啥用的，有效果的目标人群太小，赚不到钱吧
[在 staplesikea (下里巴人) 的大作中提到：]
：周末的AACR会议看样子是导火索，不过Kite 和Juno两家公司都没参加，而且诺华和
：upenn找5个重症病人没起作用也不能证明这个就对于其他solid tumor病人无效吧？
the street周末的文章是说他们的报告证明这个技术是安全的，我咋觉得不算是
negative news呢？
：...........
[在 staplesikea (下里巴人) 的大作中提到：]
：周末的AACR会议看样子是导火索，不过Kite 和Juno两家公司都没参加，而且诺华和
：upenn找5个重症病人没起作用也不能证明这个就对于其他solid tumor病人无效吧？
the street周末的文章是说他们的报告证明这个技术是安全的，我咋觉得不算是
negative news呢？
：...........
c*2
9 楼
why Kite is up and Juno continues to free fall this morning? Is it a good
time to load Juno. Other drug stocks on my watch list are all promisingly
up. (even CALA is not below yesterday's low) Only JUNO is further down 3%
today compared to yesterday's low.
time to load Juno. Other drug stocks on my watch list are all promisingly
up. (even CALA is not below yesterday's low) Only JUNO is further down 3%
today compared to yesterday's low.
c*2
10 楼
oh! just missed JUNO, it was 54.1x when I wrote last post, and now it's >58.
6% rebound in less than 8 minutes.
6% rebound in less than 8 minutes.
l*k
11 楼
一样在盯着它，眼看它瞬间拉起，追都来不及
l*r
12 楼
奇怪，为什么IB上的价格是54。XX？
【在 l****k 的大作中提到】
: 一样在盯着它，眼看它瞬间拉起，追都来不及
【在 l****k 的大作中提到】
: 一样在盯着它，眼看它瞬间拉起，追都来不及
c*2
13 楼
now it is back down to $56.5
for several minutes it was 58.23, and suddenly peak to 59.45 for seconds.
Now back down to < $57. roller coaster.
for several minutes it was 58.23, and suddenly peak to 59.45 for seconds.
Now back down to < $57. roller coaster.
相关阅读
wynn 说自己已经是“chinese company”了熊熊还是不行啊请推荐港股和A股的ETF关注RENREN，不如关注LinkedIn这么晚了还那么热闹２年前BIDU １０００元不敢想，现在到跌到１０００捞底的人会死很多花毕生积蓄张贴海报 纽约“王老师”预言521末日(zz)近期的主题是debt ceilingES 甭了如果举办options 比赛，有多少人会参加？在麦当劳的混蛋经历你们手里的股票几个水上几个水下？期待hobo 和oil oil大牛复出指导青蛙MTG/RDN/PMI是个DEAL吗开盘血跌大幅低开啊"KE Option" System started on Collective2Dapan now?两党讨价还价，花街撒泼打滚这个collective2 还有点意思